The Children's Hospital of Philadelphia's Douglas Wallace, PhD, received the 2012 Genetics Prize from the Gruber Foundation on Nov. 9 at the annual meeting of the American Society of Human Genetics (ASHG).
"The Children's Hospital of Philadelphia Research Institute is privileged to number Douglas Wallace among our research leaders," said Philip R. Johnson, MD, chief scientific officer of the CHOP Research Institute.
The Prize recognized Dr. Wallace's outstanding career contributions in shaping how mitochondria, the "power plants" inside cells, affect many different human diseases. As the director of CHOP's Center for Mitochondrial and Epigenomic Medicine, Dr. Wallace continues to pursue research that shapes new approaches to disease treatments.
"Douglas Wallace's contributions to our understanding of mitochondrial genetics have changed the way human and medical geneticists think about the role of mitochondria in human health and disease," said Dr. Elizabeth Blackburn, chair of the Selection Advisory Board to the Prize.
To read more about this prize, click here.